egfr black patients based assumption muscle mass researchers developed 2009 race remained factor presentation american society nephrology asn kidney week october 2020 university pennsylvania nephrologist nwamaka eneanya said race co efficient legacy small flawed studies published 1970s 1990s scientists developed egfr failed question findings researchers refined formula physicians continue use says downstream effects miscalculation harhay suggests not academic black patient white patient exact serum creatinine levels race co efficient says black patient seen having higher kidney function mean white patient eligible listed transplant black patient not journal general internal medicine quantified impact salman ahmed nephrologist brigham women hospital colleagues removed